Acceptance Based Telephone Support When Transitioning to SPMS
NCT04239664 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 14
Last updated 2020-09-25
Summary
What is the purpose of the study?
People with Multiple Sclerosis often say that they feel less support is available after they are diagnosed with Secondary Progressive Multiple Sclerosis, compared to before they received this diagnosis. People sometimes experience a lessening of support, despite their physical symptoms becoming more severe from both professionals and those in their personal lives. The purpose of this study is to see whether providing some telephone support to those who have recently received a diagnosis of Secondary Progressive Multiple Sclerosis is experienced as helpful and is possible to do practically. This study will help the investigators understand which type of support may be helpful for patients in the future and may pave the way for larger studies and changes to NHS provision.
Who is it for?
Participants will be those who have transitioned recently (within the last year) to Secondary Progressive Multiple Sclerosis. The investigators are inviting 40 participants to take part.
What will happen to participants if they take part?
Participants will be asked by their Neurologist or MS Nurse to take part in the study and will provide written consent to be contacted, which will be stored by the research team. Their details will be passed to the study team at the University of Nottingham, who will telephone the participant within a week to tell them a bit more about the study and ensure they are suitable for the study by asking them some questions. Following this, the participant will be sent some paper or online questionnaires to complete and return. After this, the researcher will visit the participant face to face to introduce themselves and answer any questions they may have. They will also tell the participants what "group" they have been randomly put into. There are two groups.
Those in the first group would be asked to commit to receiving a 30 minute support phonecall each week for five weeks in addition to any usual care, and the second group will receive their usual NHS care. The support phonecalls will draw from techniques used in a type of psychological therapy (acceptance and commitment therapy). All the phonecalls can be done whilst the participant is at home or in a quiet place of their choosing. After this, both groups will fill in some more paper questionnaires eight and twelve weeks after the start of the study. The investigators expect that participants will be involved in the study for around 4 months.
After the study, participants will also have the opportunity to feedback how they experienced being a participant in the study. Their responses will help the researchers understand their experience, and help them use this to think about how to adapt similar studies in the future.
Conditions
- Secondary Progressive Multiple Sclerosis
Interventions
- OTHER
-
Acceptance Based Telephone Support (ABS+UC)
Support based on Acceptance and Committment Therapy (Hayes, 1999)
Sponsors & Collaborators
-
Nottingham University Hospitals NHS Trust
collaborator OTHER -
University of Nottingham
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-09-09
- Primary Completion
- 2020-03-20
- Completion
- 2020-03-20
Countries
- United Kingdom
Study Locations
More Related Trials
-
The Feasibility of Frame Running as an Exercise Option for People With Multiple Sclerosis
NCT05234879 ·Status: COMPLETED ·Phase: NA
-
The Effect of Autologous Hematopoietic Stem Cell Transplantation on the Lower Urinary Tract Function Related to QoL in MS Patients
NCT06218927 ·Status: RECRUITING
-
Development of a Motivational Intervention to Improve Treatment Adherence in MS
NCT01925690 ·Status: COMPLETED ·Phase: NA
-
Observational Study in Multiple Sclerosis Patients Treated With Autologous Hematopoietic Stem Cell Transplantation
NCT04674280 ·Status: UNKNOWN
-
The Use of Technology to Improve MS Clinical Trials and Patient Care
NCT02454907 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Behavioural Activation for Low Mood in Multiple Sclerosis
NCT03935529 ·Status: COMPLETED ·Phase: NA
-
Using Patient-Reported Outcomes To Improve the Care of People With Multiple Sclerosis
NCT04979546 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Cyclophosphamide Versus Methylprednisolone in Patients With Secondary Progressive Multiple Sclerosis
NCT00241254 ·Status: COMPLETED ·Phase: PHASE3
-
Feasibility of Neuromodulation With Connectivity-Guided iTBS for Cognitive Impairment in MS
NCT04931953 ·Status: UNKNOWN ·Phase: NA
-
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
NCT05491031 ·Status: RECRUITING ·Phase: NA
-
Pilot Study of Free From Falls Program in Multiple Sclerosis
NCT01829776 ·Status: COMPLETED ·Phase: NA
-
Identifying and Managing Psychological Distress in Multiple Sclerosis: The COMPASS-MS Study
NCT06222359 ·Status: NOT_YET_RECRUITING
-
TakeCharge: Telephone Delivered Self-management Intervention for People With Multiple Sclerosis (MS)
NCT00944190 ·Status: COMPLETED ·Phase: NA
-
A Study Comparing Shared Solutions® Plus MS Center Support Versus Shared Solutions® Alone
NCT00240006 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Ublituximab on Motor Functions in Multiple Sclerosis
NCT06629428 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Multiple Sclerosis-Collaborative Approach to Rehabilitation Effectiveness Study
NCT02137044 ·Status: COMPLETED ·Phase: NA
-
Cortical Inhibition in Patients With Multiple Sclerosis
NCT07128160 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of MBP8298 in Subjects With Secondary Progressive Multiple Sclerosis
NCT00468611 ·Status: TERMINATED ·Phase: PHASE3
-
Impact of Multiple Sclerosis From the Viewpoint of the Caregivers
NCT02388334 ·Status: UNKNOWN
-
Development and Evaluation of the Self-management Module in Patients With Multiple Sclerosis
NCT05209113 ·Status: UNKNOWN ·Phase: NA
-
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)
NCT06270641 ·Status: RECRUITING ·Phase: NA
-
Telerehabilitation for Multiple Sclerosis
NCT06871072 ·Status: COMPLETED ·Phase: NA
-
Mindfulness-based Stress Reduction in Multiple Sclerosis
NCT02136485 ·Status: COMPLETED ·Phase: NA
-
A Randomised Controlled Trial of Neuroprotection With Lamotrigine in Secondary Progressive Multiple Sclerosis
NCT00257855 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of MD1003 in Spinal Progressive Multiple Sclerosis
NCT02220933 ·Status: UNKNOWN ·Phase: PHASE3